Vantis Vascular has filed a notice of an exempt offering of securities to raise $22,199,202.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Vantis Vascular is raising up to $22,199,202.00 in new funding. Sources indicate that as part of senior management Senior Executive, Tim Fischell played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Vantis Vascular
Vantis Vascular is revolutionizing the treatment of complex and calcific arteries with next-generation technology that allows physicians to experience superior delivery, safety, and efficiency. Founded by physicians to develop performance-driven technology for vascular interventions. We design solutions to provide faster, easier, and safer procedures, specifically targeting navigation challenges in complex, calcified, and tortuous anatomies.
To learn more about Vantis Vascular, visit http://www.vantisvascular.com/
Vantis Vascular Linkedin Page: https://www.linkedin.com/company/vantis-vascular/
Contact:
Tim Fischell, Senior Executive
269-337-7700
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.